Nina Rawal at Trill Impact Ventures on the investment in Cinclus Pharma
The Investment company Trill Impact sees Cinclus Pharma as a strong card. Nina Rawal, Co-Head of Ventures, sits on the board of Cinclus Pharma, where her biomedical experience and expertise in financing comes in handy.
Read more